NEwborn Infant of a Mother With Obesity - Fecal Microbiome Transplantation, RCT
The goal of this clinical trial is to investigate the differences in microbiota, height and weight between infants born by cesarean section to obese mothers and randomized to receive fecal microbiota transplant after birth. The main questions it aims to answer are:

Could fecal transplant be used improve gut microbiota and prevent overweight or obesity.
Is the source of colonization a modifiable factor and can it be changed by using an early fecal microbiota transplant.
- EligibilityCriteria: Inclusion Criteria:  Pregnant women age 18-49 years with obesity (prepregnancy BMI ≥ 30 kg/m2) scheduled for elective CS at term, are recruited at 36 weeks of gestation during a visit for the assessment of mode of delivery at Oulu university Hospital, Oulu, Finland.  Exclusion Criteria:  Use of regular immunosuppressive biological medication, immunodeficiency disorder of mother or other first degree family member of the unborn baby, known or suspected fetal major congenital abnormality, travelling abroad outside European countries or United States within the last three months and antibiotic treatment within 3 months of delivery (excluding the prophylactic cefuroxime (or other in case of allergy) given prior to the elective CS). Infant exclusion criteria are preterm birth (birth before 37 weeks of gestation), birth weight below 2500 g, admission to neonatal intensive care unit, need for respiratory support or antibiotic treatment of the newborn before discharge. In case of a suspected infection or newborn screening result for severe combined immunodeficiency (SCID) is out of the normal range, of the newborn the randomization code can be opened. - HealthyVolunteers: No - Gender: Female - GenderBased: Yes - GenderDescription: Pregnant women. - MinimumAge: 18 Years - MaximumAge: 49 Years - StdAgeList: Adult